RREV · RRE Ventures Acquisition Corp.
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that the Company's liquidity condition raises substantial doubt about its ability to continue as a going concern for a period of at least one year from the date these unaudited condensed financial statements are issued.”View the 10-Q filed Aug 13, 2026
Price & Indicators
The closing range uses available history since May 20, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RREV
this stock
RRE Ventures Acquisition Corp.
|
$330.67M | — | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$53.00B | — | — | — | — |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
XRPN
Armada Acquisition Corp. II
|
$764.48M | +136.3% | — | — | 0.2% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$649.10M | +2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RREV | +0.1% | +0.2% | — | +0.0% | — |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | +1.3% | +0.6% | — | +0.4% | — |